Список литературы

[1] Савельева Г. М. и др. Гинекология. Национальное руководство //М.: ГЭОТАР-Медиа. – 2020.

[2] Yuqing Chen, Lixiang Liu, Yuanna Luo, Minghui Chen, Yang Huan, Ruili Fang. Prevalence and Impact of Chronic Endometritis in Patients With Intrauterine Adhesions: A Prospective Cohort Study. J Minim Invasive Gynecol. 2017.

[3] Latika Chawla, Shashi Prateek, Anupama Bahadur, Prashant Durgapal. Intrauterine adhesions with secondary amenorrhea: A notable indicator of endometrial tuberculosis. Indian Journal of Tuberculosis 67(4)August 2020.

[4] AAGL Elevating Gynecologic Surgery AAGL Practice report: Practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE) J. Minim. Invasive Gynecol. 2017.

[5] Song D. et al. A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman’s syndrome after uterine artery embolization or surgical trauma. J Minim Invasive Gynecol. 2014.

[6] The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertil. Steril. 1988.

[7] Dreisler E., Kjer J.J. Asherman’s syndrome: Current perspectives on diagnosis and management. Int. J. Womens Health. 2019.

[8] Doroftei B., Dabuleanu A.M., Ilie O.D., Maftei R., Anton E., Simionescu G., Matei T., Armeanu T. Mini-review of the new therapeutic possibilities in Asherman syndrome—Where are we after one hundred and twenty-six years? Diagnostics. 2020.

[9] Wamsteker K. Diagnostic hysteroscopy: Technique and documentation. In: Sutton C.D., Diamond M., editors. Endoscopic Surgery for Gynecologists. WB Saunders; London, UK: 1998.

[10] March C.M. Management of Asherman’s syndrome. Rerpod. Biomed. Online. 2011.

[11] Worldwide A. A. M. I. G. AAGL practice report: practice guidelines for management of intrauterine synechiae //Journal of Minimally Invasive Gynecology. – 2010. – Т. 17. – №. 1. – С. 1-7.

[12] Yu D. Wong Y.M. Cheong Y. Xia E. Li T.C. Asherman syndrome: one century later. Fertil Steril. 2008.

[13] Fayez J.A. Mutie G. Schneider P.J. The diagnostic value of hysterosalpingography and hysteroscopy in infertility investigation. Am J Obstet Gynecol. 1987.

[14] Takeuchi M. Matsuzaki K. Nishitani H. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol. 2009.

[15] Guo J. et al. Adjuvants to prevent reformation of adhesions following adhesiolysis for Asherman syndrome: a systematic review and meta-analysis //Human Fertility. – 2023.

[16] Yasmin H. Nasir A. Noorani K.J. Hystroscopic management of Ashermans syndrome. J Pak Med Assoc. 2007.

[17] Pabuccu R. Atay V. Orhon E. Urman B. Ergün A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril. 1997.

[18] Guida M. Acunzo G. Di Spiezio Sardo A. et al. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum Reprod. 2004.

[19] Tsapanos V.S. Stathopoulou L.P. Papathanassopoulou V.S. Tzingounis V.A. The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res. 2002.

[20] cunzo G. Guida M. Pellicano M. et al. Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study. Hum Reprod. 2003.

[21] Tang R. et al. Clinical evaluation of autologous platelet-rich plasma therapy for intrauterine adhesions: a systematic review and meta-analysis //Frontiers in Endocrinology. – 2023.

[22] Conforti A. et al. The management of Asherman syndrome: a review of literature //Reproductive Biology and Endocrinology. – 2013. – Т. 11. – №. 1. – С. 118.

[23] Johary, J., Xue, M., Zhu, X., Xu, D., & Velu, P. P. (2014). Efficacy of Estrogen Therapy in Patients With Intrauterine Adhesions: Systematic Review. Journal of Minimally Invasive Gynecology, 21(1), 44–54.

[24] Liu L, Huang X, Xia E, et al. A cohort study comparing 4 mg and 10 mg daily doses of postoperative oestradiol therapy to prevent adhesion reformation after hysteroscopic adhesiolysis. Hum Fertil (Camb) 2019;22:191–7.

[25] Е.Ю. Глухов, Г.Б. Дикке, Е.И. Нефф, В.Е. Глухова, Д.А. Березина.Опыт применения комплексной терапии при лечении больных с синдромом Ашермана. Фарматека 2021.

[26] Johary J, Xue M, Zhu X, Xu D, Velu PP. Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review. J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):44-54.

[27] Miriam M. F. et al. Hormonal support in women with Asherman syndrome does not lead to better outcomes: A randomized trial. Reproductive Medicine and BiologyVolume 22, Issue 1 Hormonal support in women with Asherman syndrome does not lead to better outcome.

[28] Dan-Er Qiu et al. Comparison of the Reproductive Outcome Between 2 and 4 mg Daily Doses of Estradiol After Hysteroscopic Adhesiolysis: A Propensity Score Matching Analysis–Retrospective Cohort Study. Front. Endocrinol., 13 June 2022Sec. Reproduction Volum.

[29] AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). 01 May 2017.

[30] Kuramoto G.,Takagi S.et al. Preventive effect of oral mucosal epithelial cell sheets on intrauterine adhesions. Hum Reprod. 2015. .

[31] Santamaria X. et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016. .

[32] Smikle C., Yarrarapu S. N. S., Khetarpal S. Asherman Syndrome.[Updated 2022 Jun 27] //StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. .

[33] Urman B. et al. Fertility and anatomical outcomes following hysteroscopic adhesiolysis: An 11‐year retrospective cohort study to validate a new classification system for intrauterine adhesions (Urman‐Vitale Classification System) - 2024. .

[34] Hamou J., Salat-Baroux J. Siegler A.M. Diagnosis and treatment of intrauterine adhesions by microhysteroscopy. Fertil Steril. 1983. .

[35] Куликова Н. Г. и др. Реабилитация в гинекологической и акушерской практике методами физиотерапии и рефлексотерапии. – 2023. .

[36] Хириева П. М., Адамян Л. В. Клинико-анамнестические данные и исходы лечения женщин с внутриматочными синехиями //Проблемы репродукции. – 2017. – Т. 23. – №. 6. – С. 39-44. .

[37] Valle R.F. Sciarra J.J. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988. .

[38] Lee WL, Liu CH, Cheng M, Chang WH, Liu WM, Wang PH. Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision. Int J Mol Sci. 2021. .

[39] March C.M., Israel R., March A.D. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol. 1978. .

[40] Wamsteker K. De Blok S.J. Diagnostic hysteroscopy: technique and documentation. in: Sutton C. Diamon M. Endoscopic Surgery for Gynecologists. Lippincott Williams & Wilkins Publishers, New York1995. .

[41] Donnez J. Nisolle M. Hysteroscopic lysis of intrauterine adhesions (Asherman syndrome). in: Donnez J. Atlas of Laser Operative Laparoscopy and Hysteroscopy. Press-Parthenon, New York, New York1994. .

[42] Nasr A.L. Al-Inany H. Thabet S. Aboulghar M. A clinicohysteroscopic scoring system of intrauterine adhesions. Gynecol Obstet Invest. 2000. .